Skip to content

Green Tea Anticancer Mechanisms in Smokers

Green Tea Anticancer Mechanisms in Smokers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01162642
Enrollment
43
Registered
2010-07-14
Start date
2010-06-30
Completion date
2013-08-31
Last updated
2015-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Healthy moderately heavy smokers

Brief summary

The purpose of this study is to determine whether green tea may lower the risk of certain cancers.

Detailed description

Green tea contains phytochemicals, especially flavonoids. Phytochemicals are not absolutely required for normal functions, but may confer health benefits such as antioxidant actions. One can live without phytochemicals, but one may live longer and better with them. The phytochemicals in tea have been proposed to inhibit cancer onset via several different mechanisms. An obvious question is: Can anti-cancer actions of green tea be duplicated by black tea, which in the USA, is consumed more than green tea? The question remains unanswered, and will not be addressed by this project since many questions about green tea have not been answered yet. The contents of both type teas overlap in flavonoids, but green tea has more of the agents thought to be most effective. For example, some of the research cited below uses the flavonoid epigallocatechin gallate. Green tea has 5 times more of this flavonoid than black tea. This study has two purposes. First, a case will be made that green tea may have several anti-cancer mechanisms, but this contention is not well confirmed by human intervention studies. This case will be made by addressing four questions. Second, justification will be given for the choice of mechanisms to be examined in this project's human intervention.

Interventions

DIETARY_SUPPLEMENTGreen Tea

Green Tea 4 cups daily

OTHERPlacebo

4 cups placebo tea for 6 weeks

Sponsors

Philip Diaz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
23 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy 23-40 year old males and non-pregnant females, who are moderately heavy smokers (1-1.75 packs/day, \> 2 years)

Exclusion criteria

* Habitual tea intake * Habitual flavonoid supplementation * Soy product intake over twice a week (soy is high in flavonoids). * Pulmonary diseases * Chronic or acute infection * Admission of heavy alcohol intake (\> 14 beers or drinks a week) * Body mass index (BMI) \> 30 (moderately overweight subjects will be taken) * Abnormal EKG * History of heart or other major health problems (ie arthritis, diabetes). * Subjects with slightly high blood pressure will be eligible for the project, but more severe hypertension (\>150/100)

Design outcomes

Primary

MeasureTime frameDescription
Antioxidant effects of green tea versus placebo consumption.Measured at post treatmentExamine antioxidant effects of green tea versus placebo by measuring scavenging of free radicals; tea flavonoids; inflammatory cell secretion; endogenous antioxidant glutathione.

Secondary

MeasureTime frameDescription
Non-antioxidant, cancer-relevant effects of green tea consumptionMeasured at pre-treatment and post treatmentExamine non-antioxidant, cancer-relevant effects of green tea by measuring NF-kappaB inducing kinase; phosphorylation of cell signaling agents; tumor necrosis factor gene expression; lysyl oxidase enzyme; blockage of cancer cell proliferation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026